• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COV

CLEO DIAGNOSTICS LTD

3.90% ! 37.0¢
Market Cap $30.19M  !

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. Triage Test is a pre-surgical test to determine ovarian or adnexal mass for which surgical referral is required who have not yet been referred to an oncologist.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
COV 21/07/25 1 485
21/07/25 Last post  tonyjones22 Comments Created with Sketch.  1  Views Created with Sketch.  485 
COV 15/07/25 6 2.0K
15/07/25 Last post  Dimitrios63 Comments Created with Sketch.  6  Views Created with Sketch.  2.0K 
COV 11/07/25 7 3.0K
TRENDING NEWS

Exclusive Pre-IPO & Investment Opportunities in Australia & North America

NEWS
29 Jul 2025
11/07/25 Last post  SpiralNotebook Comments Created with Sketch.  7  Views Created with Sketch.  3.0K 
COV 09/07/25 10 3.2K
09/07/25 Last post  ma420 Comments Created with Sketch.  10  Views Created with Sketch.  3.2K 
COV 25/06/25 12 4.4K
25/06/25 Last post  AirForce100 Comments Created with Sketch.  12  Views Created with Sketch.  4.4K 
COV 25/06/25 0 438
25/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  438 
COV 12/05/25 0 520
12/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  520 
COV 24/04/25 0 284
24/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  284 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly activities and cashflow report
21 Jul 09:09
 
CLEO Strengthens FDA Submission - Access to US Biobank
25 Jun 09:58
 
Investor Webinar
18 Jun 08:48
 
Corporate Presentation
12 Jun 08:33
 
Cleo Advances with Completion of Alpha Testing
12 May 10:17
 
CLEO to Fast Track Development of Ovarian Cancer Test
28 Apr 09:09
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
37.0¢
Change
-0.015(3.90%)
Mkt cap ! $30.19M
Open High Low Value Volume
39.5¢ 39.5¢ 36.5¢ $27.02K 72.27K

Buyers (Bids)

No. Vol. Price($)
2 26912 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 17085 2
View Market Depth
Last trade - 14.52pm 29/07/2025 (20 minute delay) ?
COV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.